Vinorelbine and Carmustine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vinorelbine (vinorelbine) and Carmustine (carmustine). Common drug interactions include staphylococcal infection among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Vinorelbine and Carmustine. It is created by eHealthMe based on reports of 48 people who take the same drugs from the FDA, and is updated regularly.

What is Vinorelbine?

Vinorelbine has active ingredients of vinorelbine. eHealthMe is studying from 6,381 Vinorelbine users. Check the latest studies of Vinorelbine.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

On Aug, 02, 2026

48 people who take Vinorelbine and Carmustine together, and have interactions are studied.

Vinorelbine and Carmustine drug interactions.

What are the common drug interactions of Vinorelbine and Carmustine, by gender? *:

female:

Staphylococcal infection (an infection with staphylococcus bacteria)
Thrombocytopenia (decrease of platelets in blood)
Disease progression
Cold type haemolytic anaemia (anaemia of abnormal breakdown of red blood cells)
Haematotoxicity (toxins that destroy red blood cells)
Multiple-drug resistance
Non-hodgkin's lymphoma recurrent (reoccurrence malignant (cancer) cells form in the lymph system)
Aplasia (defective development or congenital absence of an organ or tissue)
Bacteraemia (presence of bacteria in the blood)
Febrile neutropenia (fever with reduced white blood cells)

male:

Asthenia (weakness)
Pneumonia
Malignant neoplasm progression (cancer tumour came back)
Hodgkin's disease (cancer originating from white blood cells)
Cardiac failure
Csf protein increased
Death
Dyspnoea exertional (breathlessness or shortness of breath)
Febrile neutropenia (fever with reduced white blood cells)
Rash

What are the common drug interactions of Vinorelbine and Carmustine, by age (0-1 to 60+)? *:

0-1:

Disease progression
Drug ineffective

2-9:

n/a

10-19:

Dyspnoea exertional (breathlessness or shortness of breath)
Autoimmune neutropenia (autoimmune neutropenia is abnormally low level of neutrophils in the blood)
Autoimmune pancytopenia (abnormal deficiency in all blood cells by immune system deficiency)
Bacterial infection
Cardiomegaly (increased size of heart than normal)
Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
Interstitial lung disease
Oedema peripheral (superficial swelling)
Post transplant lymphoproliferative disorder
Systemic candida (whole body fungal infection)

20-29:

Capnocytophaga infection (bacterial infection)
Disease progression
Enterococcal infection
Neutropenia (an abnormally low number of neutrophils)
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Stomatitis (inflammation of mucous membrane of mouth)

30-39:

Anaemia (lack of blood)
Cardiac failure
Febrile neutropenia (fever with reduced white blood cells)
Renal impairment (severely reduced kidney function)
Blood disorder
Ejection fraction decreased (systolic heart failure)
Hodgkin's disease recurrent (cancer originating from white blood cells -recurrent)

40-49:

Asthenia (weakness)
Pneumonia
Pruritus (severe itching of the skin)
Pyrexia (fever)
Drug ineffective
Disease progression
Neutropenia (an abnormally low number of neutrophils)
Malignant neoplasm progression (cancer tumour came back)
Hodgkin's disease (cancer originating from white blood cells)

50-59:

Cold type haemolytic anaemia (anaemia of abnormal breakdown of red blood cells)
Disease progression
Haematotoxicity (toxins that destroy red blood cells)
Non-hodgkin's lymphoma recurrent (reoccurrence malignant (cancer) cells form in the lymph system)
Aplasia (defective development or congenital absence of an organ or tissue)
Bacteraemia (presence of bacteria in the blood)
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal inflammation (inflammation of stomach and intestine)
Multiple-drug resistance
Platelet disorder

60+:

Csf protein increased
Rash
Anaemia (lack of blood)
Bone pain
Infusion related reaction
Multiple-drug resistance

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 26 people, 54.17%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 12 people, 25.00%
Burkitt Lymphoma (cancer of the lymphatic system): 7 people, 14.58%
Bone Marrow Conditioning Regimen: 5 people, 10.42%

* Approximation only. Some reports may have incomplete information.

Do you take Vinorelbine and Carmustine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously